Rick Doblin, Founder and Executive Director of the Multidisciplinary Association of Psychedelic Studies (MAPS) will be joined by Christian Angermayer, Founder of atai Life Sciences, to discuss how for-profit and non-profit psychedelic organisations can co-exist and achieve objectives in today’s increasingly competitive business landscape.
